Primary leptomeningeal melanoma is part of the BAP1-related cancer syndrome

Acta Neuropathologica

Volumn 129, Issue 6, 2015, Pages 921-923

  de la Fouchardière, Arnaud ^a   Cabaret, Odile ^b   Pètre, Justine ^c   Aydin, Selda ^c   Leroy, Alice ^c   de Potter, Patrick ^c   Pissaloux, Daniel ^a   Haddad, Véronique ^a   Bressac de Paillerets, Brigitte ^b   Janin, Nicolas ^c  

^a CENTRE LÉON BÉRARD   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BRCA1 ASSOCIATED PROTEIN 1; HYDROLASE; RAS PROTEIN; UNCLASSIFIED DRUG; BAP1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE;

ADULT; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; COMPARATIVE GENOMIC HYBRIDIZATION; EXON; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRACRANIAL HYPERTENSION; LETTER; MELANOCYTE; MELANOMA; MENINGIOMA; MITOSIS; MULTIPLE CANCER; PRIMARY LEPTOMENINGEAL MELANOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; THYROID CARCINOMA; FAMILY HEALTH; GENETICS; MUTATION; NUCLEOTIDE SEQUENCE;

ADULT; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; HUMANS; MELANOMA; MENINGEAL NEOPLASMS; MUTATION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84929706460     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-015-1423-2     Document Type: Letter

References (11)

1. Battaglia A (2014) The importance of multidisciplinary approach in early detection of BAP1 tumor predisposition syndrome: clinical management and risk assessment. Clin Med Insights Oncol 8:37–47. doi:10.4137/CMO.S15239
2. Brat DJ, Giannini C, Scheithauer BW, Burger PC (1999) Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol 23:745–754
3. Cassoux N, Rodrigues MJ, Plancher C, Asselain B, Levy-Gabriel C, Lumbroso-Le Rouic L, Piperno-Neumann S et al (2014) Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma. Br J Ophthalmol 98:769–774. doi:10.1136/bjophthalmol-2013-303867
4. de la Fouchardiere A, Cabaret O, Savin L, Combemale P, Schvartz H, Penet C, Bonadona V et al (2014) Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clin Genet, doi:10.1111/cge.12472
5. Koopmans AE, Verdijk RM, Brouwer RW, van den Bosch TP, van den Berg MM, Vaarwater J, Kockx CE et al (2014) Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod Pathol 27:1321–1330. doi:10.1038/modpathol.2014.43
6. Kusters-Vandevelde HV, Klaasen A, Kusters B, Groenen PJ, van Engen-van Grunsven IA, van Dijk MR, Reifenberger G et al (2010) Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system. Acta Neuropathol 119:317–323. doi:10.1007/s00401-009-0611-3
7. Kusters-Vandevelde HV, van Engen-van Grunsven IA, Coupland SE, Lake SL, Rijntjes J, Pfundt R, Kusters B et al (2014) Mutations in G protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms. Pathol Oncol Res. Epub_ahead_of_print
8. Lee Y, Liu J, Patel S, Cloughesy T, Lai A, Farooqi H, Seligson D et al (2010) Genomic landscape of meningiomas. Brain Pathol 20:751–762. doi:10.1111/j.1750-3639.2009.00356.x
9. Murali R, Wiesner T, Rosenblum MK, Bastian BC (2012) GNAQ and GNA11 mutations in melanocytomas of the central nervous system. Acta Neuropathol 123:457–459. doi:10.1007/s00401-012-0948-x
10. Murali R, Wiesner T, Scolyer RA (2013) Tumours associated with BAP1 mutations. Pathology 45:116–126. doi:10.1097/PAT.0b013e32835d0efb
11. Shirley MD, Tang H, Gallione CJ, Baugher JD, Frelin LP, Cohen B, North PE et al (2013) Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 368:1971–1979. doi:10.1056/NEJMoa1213507